Diphenhydramin: Fachinformation – Dosierung, Gegenanzeigen, Wechselwirkungen, Nebenwirkungen
Für Fachkreise
Anwendungsgebiete
Diphenhydraminhydrochlorid ist in oraler Form bei den folgenden Indikationen wirksam:
Antihistaminisch
Bei allergischer Konjunktivitis durch Nahrungsmittel; leichten, unkomplizierten allergischen Hautmanifestationen von Urtikaria und Angioödem; zur Linderung allergischer Reaktionen auf Blut oder Plasma; Dermographismus; als Therapie anaphylaktischer Reaktionen ergänzend zu Epinephrin und anderen Standardmaßnahmen, nachdem die akuten Manifestationen unter Kontrolle gebracht wurden.
Reisekrankheit
Zur aktiven und prophylaktischen Behandlung der Reisekrankheit.
Antiparkinsonmittel
Bei Parkinsonismus (einschließlich arzneimittelinduziertem) bei älteren Menschen, die stärker wirksame Mittel nicht vertragen; bei leichten Fällen von Parkinsonismus (einschließlich arzneimittelinduziertem) in anderen Altersgruppen; in anderen Fällen von Parkinsonismus (einschließlich arzneimittelinduziertem) in Kombination mit zentral wirkenden Anticholinergika.
Schlafmittel für die Nacht.
Englisches Original anzeigen
Diphenhydramine hydrochloride in the oral form is effective for the following indications:
Antihistaminic
For allergic conjunctivitis due to foods; mild, uncomplicated allergic skin manifestations of urticaria and angioedema; amelioration of allergic reactions to blood or plasma; dermatographism; as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled.
Motion Sickness
For active and prophylactic treatment of motion sickness.
Antiparkinsonism
For parkinsonism (including drug-induced) in the elderly unable to tolerate more potent agents; mild cases of parkinsonism (including drug-induced) in other age groups; in other cases of parkinsonism (including drug-induced) in combination with centrally acting anticholinergic agents.
Nighttime Sleep-aid.
Dosierung und Art der Anwendung
DIE DOSIERUNG SOLLTE ENTSPRECHEND DEM BEDARF UND DEM ANSPRECHEN DES PATIENTEN INDIVIDUELL ANGEPASST WERDEN.
Eine orale Einzeldosis Diphenhydraminhydrochlorid wird rasch resorbiert, wobei die maximale Wirkung nach etwa einer Stunde eintritt. Die Wirkdauer nach einer durchschnittlichen Dosis Diphenhydraminhydrochlorid beträgt vier bis sechs Stunden.
Erwachsene
25 bis 50 mg drei- oder viermal täglich. Die Dosierung als Schlafmittel für die Nacht beträgt 50 mg vor dem Schlafengehen.
Kinder und Jugendliche, ausgenommen Frühgeborene und Neugeborene
12,5 bis 25 mg drei- oder viermal täglich. Die maximale Tagesdosis darf 300 mg nicht überschreiten. Für Ärzte, die die Dosis auf Basis des Körpergewichts oder der Körperoberfläche berechnen möchten, beträgt die empfohlene Dosierung 5 mg/kg/24 Stunden oder 150 mg/m²/24 Stunden.
Zur Anwendung von Diphenhydraminhydrochlorid als Schlafmittel für die Nacht bei Kindern unter 12 Jahren liegen keine Daten vor.
Grundlage für die Bestimmung des wirksamsten Dosierungsschemas ist das Ansprechen des Patienten auf das Arzneimittel und die zu behandelnde Erkrankung.
Bei Reisekrankheit wird zur prophylaktischen Anwendung die volle Dosierung empfohlen, wobei die erste Dosis 30 Minuten vor Beginn der Bewegungsexposition und vergleichbare Dosen vor den Mahlzeiten und beim Zubettgehen für die Dauer der Exposition gegeben werden.
Englisches Original anzeigen
DOSAGE SHOULD BE INDIVIDUALIZED ACCORDING TO THE NEEDS AND THE RESPONSE OF THE PATIENT.
A single oral dose of diphenhydramine hydrochloride is quickly absorbed with maximum activity occurring in approximately one hour. The duration of activity following an average dose of diphenhydramine hydrochloride is from four to six hours.
Adults
25 to 50 mg three or four times daily. The nighttime sleep-aid dosage is 50 mg at bedtime.
Pediatric Patients, other than premature infants and neonates
12.5 to 25 mg three or four times daily. Maximum daily dosage not to exceed 300 mg. For physicians who wish to calculate the dose on the basis of body weight or surface area, the recommended dosage is 5 mg/kg/24 hours or 150 mg/m²/24 hours.
Data are not available on the use of diphenhydramine hydrochloride as a nighttime sleep-aid in children under 12 years.
The basis for determining the most effective dosage regimen will be the response of the patient to medication and the condition under treatment.
In motion sickness, full dosage is recommended for prophylactic use, the first dose to be given 30 minutes before exposure to motion and similar doses before meals and upon retiring for the duration of exposure.
Gegenanzeigen
Anwendung bei Neugeborenen oder Frühgeborenen
Dieses Arzneimittel sollte bei Neugeborenen oder Frühgeborenen nicht angewendet werden.
Anwendung bei stillenden Müttern
Aufgrund des höheren Risikos von Antihistaminika für Säuglinge im Allgemeinen und für Neugeborene und Frühgeborene im Besonderen ist eine Antihistaminika-Therapie bei stillenden Müttern kontraindiziert.
Antihistaminika sind außerdem bei den folgenden Zuständen kontraindiziert
Überempfindlichkeit gegen Diphenhydraminhydrochlorid und andere Antihistaminika mit ähnlicher chemischer Struktur.
Englisches Original anzeigen
Use in Neonates or Premature Infants
This drug should not be used in neonates or premature infants.
Use in Nursing Mothers
Because of the higher risk of antihistamines for infants generally, and for neonates and prematures in particular, antihistamine therapy is contraindicated in nursing mothers.
Antihistamines are also contraindicated in the following conditions
Hypersensitivity to diphenhydramine hydrochloride and other antihistamines of similar chemical structure.
Nebenwirkungen
The most frequent adverse reactions are underscored.
- General: Urticaria, drug rash, anaphylactic shock, photosensitivity, excessive perspiration, chills, dryness of the mouth, nose and throat.
- Cardiovascular System: Hypotension, headache, palpitations, tachycardia, extrasystoles.
- Hematologic System: Hemolytic anemia, thrombocytopenia, agranulocytosis.
- Nervous System: Sedation, sleepiness, dizziness, disturbed coordination, fatigue, confusion, restlessness, excitation, nervousness, tremor, irritability, insomnia, euphoria, paresthesia, blurred vision, diplopia, vertigo, tinnitus, acute labyrinthitis, neuritis, convulsions.
- GI System: Epigastric distress, anorexia, nausea, vomiting, diarrhea, constipation.
- GU System: Urinary frequency, difficult urination, urinary retention, early menses.
- Respiratory System: Thickening of bronchial secretions, tightness of chest or throat and wheezing, nasal stuffiness.
To report SUSPECTED ADVERSE REACTIONS, contact Redmont Pharmaceuticals, Inc. at 1-800-986-5909 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Warnhinweise und Vorsichtsmaßnahmen
Antihistamines should be used with considerable caution in patients with narrow-angle glaucoma, stenosing peptic ulcer, pyloroduodenal obstruction, symptomatic prostatic hypertrophy, or bladder-neck obstruction.
Use in Pediatric Patients
In pediatric patients, especially, antihistamines in overdosage may cause hallucinations, convulsions, or death. As in adults, antihistamines may diminish mental alertness in pediatric patients. In the young pediatric patient, particularly, they may produce excitation.
Use in the Elderly (approximately 60 years or older)
Antihistamines are most likely to cause dizziness, sedation, and hypotension in elderly patients.
Vorsichtsmaßnahmen
General
Diphenhydramine hydrochloride has an atropine-like action and therefore, should be used with caution in patients with a history of bronchial asthma, increased intraocular pressure, hyperthyroidism, cardiovascular disease or hypertension. Use with caution in patients with lower respiratory disease including asthma.
Information for Patients
Patients taking diphenhydramine hydrochloride should be advised that this drug may cause drowsiness and has an additive effect with alcohol. Patients should be warned about engaging in activities requiring mental alertness such as driving a car or operating appliances, machinery, etc.
Drug Interactions
Diphenhydramine hydrochloride has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc.). MAO inhibitors prolong and intensify the anticholinergic (drying) effects of antihistamines.
Carcinogenesis, Mutagenesis, Impairment of Fertility
Long-term studies in animals to determine mutagenic and carcinogenic potential have not been performed.
Pregnancy
Pregnancy Category B
Reproduction studies have been performed in rats and rabbits at doses up to 5 times the human dose and have revealed no evidence of impaired fertility or harm to the fetus due to diphenhydramine hydrochloride. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.
Pediatric Use
Diphenhydramine hydrochloride should not be used in neonates and premature infants (see CONTRAINDICATIONS ).
Diphenhydramine hydrochloride may diminish mental alertness, or, in the young pediatric patient, cause excitation. Overdosage may cause hallucinations, convulsions, or death (see WARNINGS and OVERDOSAGE ).
See also DOSAGE AND ADMINISTRATION section.
Überdosierung
Antihistamine overdosage reactions may vary from central nervous system depression to stimulation. Stimulation is particularly likely in pediatric patients. Atropine-like signs and symptoms, dry mouth; fixed, dilated pupils; flushing and gastrointestinal symptoms may also occur.
If vomiting has not occurred spontaneously, the patient should be induced to vomit. This is best done by having him drink a glass of water or milk after which he should be made to gag. Precaution against aspiration must be taken, especially in infants and children.
If vomiting is unsuccessful, gastric lavage is indicated within 3 hours after ingestion and even later if large amounts of milk or cream were given beforehand. Isotonic or 1/2 isotonic saline is the lavage solution of choice.
Saline cathartics, as milk of magnesia, by osmosis draw water into the bowel and therefore are valuable for their action in rapid dilution of bowel content.
Stimulants should not be used.
Vasopressors may be used to treat hypotension.
Klinische Pharmakologie
Diphenhydramine hydrochloride is an antihistamine with anticholinergic (drying) and sedative effects. Antihistamines appear to compete with histamine for cell receptor sites on effector cells.
A single oral dose of diphenhydramine hydrochloride is quickly absorbed with maximum activity occurring in approximately one hour. The duration of activity following an average dose of diphenhydramine hydrochloride is from four to six hours. Diphenhydramine is widely distributed throughout the body, including the CNS. Little, if any, is excreted unchanged in the urine; most appears as the degradation products of metabolic transformation in the liver, which are almost completely excreted within 24 hours.
Quelle: U.S. Food and Drug Administration (FDA), Prescribing Information, über DailyMed (NLM); gemeinfrei. Keine Werbung, keine Therapieempfehlung. Bei Fragen zur eigenen Behandlung: Ärztin, Arzt oder Apotheke.